Detail Information of Genetic Polymorphisms
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0452 Transporter Info | ||||
Gene Name | SLC6A2 | ||||
Protein Name | Sodium-dependent noradrenaline transporter | ||||
Gene ID | |||||
UniProt ID | |||||
Genetic Polymorphisms of DT (GPD) | |||||
Genetic Polymorphism | rs12708954 | ||||
Site of GPD | chr16:55697687 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | C>A | ||||
Minor Allele Frequency | A=0.1853/928 (Global) | ||||
Allele A | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Atomoxetine | Drug Info | Attention Deficit Disorder With Hyperactivity | Correlated with the increased drug response in patients (compare with allele C) | [ 1] | |
Genetic Polymorphism | rs2242446 | ||||
Site of GPD | chr16:55656513 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | C>A / C>T | ||||
Minor Allele Frequency | C=0.2470/1237 (Global) | ||||
Genotype CC | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Venlafaxine | Drug Info | Major Depressive Disorder | Correlated with the increased drug response in patients (compare with Genotypes CT + TT) | [ 2] | |
Genotype TT | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
3,4-Methylenedioxymethamphetamine | Drug Info | Posttraumatic Stress Disorder | Correlated with the decreased drug response (compare with genotypes CC + CT) | [ 3] | |
Genetic Polymorphism | rs36029 | ||||
Site of GPD | chr16:55662844 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | A>G | ||||
Minor Allele Frequency | G=0.3978/1992 (Global) | ||||
Genotype AA | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
3,4-Methylenedioxymethamphetamine | Drug Info | Posttraumatic Stress Disorder | Correlated with the increased drug response in patients (compare with genotypes AG + GG) | [ 3] | |
Genetic Polymorphism | rs3785143 | ||||
Site of GPD | chr16:55661194 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | C>T | ||||
Minor Allele Frequency | T=0.1048/525 (Global) | ||||
Allele T | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Atomoxetine | Drug Info | Attention Deficit Disorder With Hyperactivity | Correlated with the decreased drug response in patients (compare with allele C) | [ 4] | |
Genetic Polymorphism | rs5569 | ||||
Site of GPD | chr16:55697923 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | G>A / G>C | ||||
Minor Allele Frequency | A=0.2334/1169 (Global) | ||||
Allele A | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Methylphenidate | Drug Info | Attention Deficit Disorder With Hyperactivity | Irrelevant to the drug response in patients (compare with Allele G) | [ 5] | |
Genotype GG | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Methylphenidate | Drug Info | Attention Deficit Disorder With Hyperactivity | Correlated with the increased drug response in patients (compare with genotypes AA + AG) | [ 6] | |
Genetic Polymorphism | rs1861647 | ||||
Site of GPD | chr16:55694494 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | G>A / G>C | ||||
Minor Allele Frequency | A=0.2384/1194 (Global) | ||||
Genotype GG | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
3,4-Methylenedioxymethamphetamine | Drug Info | Posttraumatic Stress Disorder | Correlated with the increased drug response (compare with genotypes AA + AG) | [ 3] | |
References | |||||
1 | A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD). Neuropsychopharmacology. 2009 Aug;34(9):2135-42. | ||||
2 | Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults. Am J Psychiatry. 2017 May 1;174(5):468-475. | ||||
3 | No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA. Eur J Clin Pharmacol. 2018 Mar;74(3):275-283. | ||||
4 | Adrenergic neurotransmitter system transporter and receptor genes associated with atomoxetine response in attention-deficit hyperactivity disorder children. J Neural Transm (Vienna). 2013 Jul;120(7):1127-33. | ||||
5 | Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD. Psychiatry Res. 2011 Apr 30;186(2-3):338-44. | ||||
6 | Norepinephrine transporter gene (SLC6A2) is involved with methylphenidate response in Korean children with attention deficit hyperactivity disorder. Int Clin Psychopharmacol. 2011 Mar;26(2):107-13. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.